Globus Medical (GMED) Reports In-Line Q2 EPS

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.25, in-line with the analyst estimate of $0.25. Revenue for the quarter came in at $133.6 million versus the consensus estimate of $126.89 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• Option Care Health (OPCH) Tops Q1 EPS by 3c, provides guidance
• Philip Morris (PM) beats Q1 earnings, revenue estimates; issues upbeat guidance